However, despite the advancement characterized by these findings, limited information is available about the role of the hydroxylation Trp–5‐HT metabolic pathway in tumor progression, and the mechanisms underlying the action of 5-HT and its receptors associated with tumor behavior remain unknown. The gene discussed is HTR5A; the disease is neoplasm.